Medtronic + Chengdu High-tech Zone
Medtronic
Minneapolis, Minnesota · 2 relationships
Active relationship
Government Partnership · 2016–present
Chengdu High-tech Zone
Chengdu, Sichuan · 1 relationship
Analysis
Medtronic and the Chengdu municipal government announced an insulin-pump manufacturing agreement on January 11, 2016, building on a broader strategic partnership signed by the city and Medtronic in September 2015. The agreement called for a Chengdu manufacturing facility for a next-generation sensor-augmented pump system with SmartGuard technology, linking local production to the partners' stated goal of expanding access to diabetes therapies. [1]
The arrangement included a localization element beyond assembly. Medtronic said it would work with the Chengdu government to make the locally produced technology available to people with diabetes in Chengdu and Sichuan, with software displayed in Chinese. The 2015 strategic agreement had committed both sides to expand access to proven therapies, particularly diabetes-management solutions, in China and other countries. [1]
The insulin-pump facility was presented as the second Medtronic plant announced in Chengdu within roughly 18 months. The earlier project, announced in August 2014, was intended to create Medtronic's first worldwide factory for portable hemodialysis equipment, making Chengdu a location for multiple locally oriented medical-device production programs rather than a single product line. [1] [2]
Medtronic later described the Chengdu site as part of a broader local value chain. In 2017 it identified the insulin-pump and hemodialysis projects as preceding a planned medical innovation center; in 2021 the center opened as an approximately 8,800-square-meter multidisciplinary clinical-training and exchange platform, while Medtronic reported that its Chengdu factory was the company's first insulin-pump factory outside the United States and that a locally developed pump had reached volume production. The public materials establish the manufacturing and training roles, but do not disclose a current standalone production volume or partnership financial statement. [2] [3]
Participants
Continue through either entity
Minneapolis, Minnesota · 2 records in this database
Medtronic was founded in Minneapolis in 1949 by electrical engineer Earl Bakken and his brother-in-law, Palmer Hermundslie, as a business repairing medical electronics. The company’s history describes the early operation as a small workshop that expanded from repairs into custom medical equipment, with the founders’ engineering work closely connected to clinicians and hospitals. [1] [2]
A power outage in Minneapolis on Halloween 1957 exposed the risks of the bulky, outlet-powered pacemakers then used after open-heart surgery. At the request of University of Minnesota heart surgeon C. Walton Lillehei, Bakken developed a wearable, battery-operated pacemaker within four weeks; Medtronic’s history says the company produced its first implantable pacemaker one year later, while a separate company account identifies commercialization of the first implantable pacemaker in 1960. [1] [2]
Medtronic has since developed a broad medical-technology portfolio. Its current key-facts page says its technologies address more than 70 health conditions through cardiovascular, medical-surgical and neuroscience portfolios, including electrophysiology, interventional cardiology, peripheral vascular health, acute care and monitoring, endoscopy, surgery, cranial and spinal technologies, neuromodulation and neurovascular care. The page reports FY25 figures of 174 active clinical trials, $2.7 billion in research-and-development investment and more than 41,000 active patent matters. [3]
The company’s current corporate structure also reflects its international scale. Following the 2014 agreement to acquire Covidien, Medtronic said Medtronic plc would be the parent company, with principal executive offices in Ireland and operational headquarters in Minneapolis. This supports retaining Minneapolis as the operational headquarters in the entity record while distinguishing it from the parent company’s Irish administrative headquarters. [4]
Medtronic’s inclusion in this database is associated with its medical-technology partnerships and clinical ecosystem, but its own identity is rooted in engineering-led device development. The company’s current key-facts page says its technologies have served more than 74 million patients and that its mission is pursued through products and therapies spanning the three listed solution portfolios. [3]
Chengdu, Sichuan · 1 record in this database
Chengdu High-Tech Industrial Development Zone was founded in 1988 and is described by China’s National Intellectual Property Administration as one of the country’s first high-tech zones. [1] In 2015 it became the first national independent-innovation demonstration zone in western China. [1] The designation gave the zone a policy role in experimenting with entrepreneurship, technology commercialization, talent recruitment, intellectual-property management and protection, science-and-finance combinations, and integrated industrial and urban development. [1]
The zone’s current industrial profile is built around electronic information, biomedicine and the digital economy, with artificial intelligence identified by Sichuan’s industry authority as an emerging area being laid out in the zone. [2] A 2024 government report on a provincial high-tech-zone inspection specifically described visits to integrated-circuit, low-altitude-aircraft and computing-hardware companies in Chengdu High-Tech Zone, linking the zone’s development to advanced manufacturing and new forms of productive technology. [2]
A 2025 Sichuan market-regulation report describes the zone as using a “one zone, four parks” spatial layout and focusing on three trillion-yuan-level clusters—electronic information, biomedicine and the digital economy. [3] It also identifies a national intellectual-property new-economy demonstration park within the zone. [3] In the same year, the Chengdu zone’s national IP-service-industry demonstration area signed a cooperation agreement with the Mianyang Science and Technology City New Area, covering talent training, shared patent and technology-map resources, cross-regional services and overseas rights protection. [3]
These sources present Chengdu High-Tech Zone as an institutional platform that combines land and business administration with innovation policy, intellectual-property services, research commercialization and technology-intensive industry. [1] [2] [3] Its role in the database is therefore regional and ecosystem-based: it is a public development zone through which companies, research organizations and technology partnerships can access an organized innovation environment. [1] [2] [3]